# A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

> **NCT06311682** · PHASE3 · RECRUITING · sponsor: **LEO Pharma** · enrollment: 195 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Tralokinumab + TCS
- **DRUG:** Placebo + TCS

## Key facts

- **NCT ID:** NCT06311682
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-10
- **Primary completion:** 2026-10-20
- **Final completion:** 2028-04-28
- **Target enrollment:** 195 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06311682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06311682, "A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06311682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*